Results 211 to 220 of about 250,417 (383)
Inherited metabolic epilepsies–established diseases, new approaches
Epilepsia Open, EarlyView.Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley +1 more source
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. [PDF]
, 1976 A. J. Garber +5 more
openalex +1 more source
New insights into epileptic spasm generation and treatment from the TTX animal model
Epilepsia Open, EarlyView.Abstract Currently, we have an incomplete understanding of the mechanisms underlying infantile epileptic spasms syndrome (IESS). However, over the past decade, significant efforts have been made to develop IESS animal models to provide much‐needed mechanistic information for therapy development.
John W. Swann +2 more
wiley +1 more source
Spontaneous Hypoglycemia Treated by Partial Pancreatectomy
, 1962 Howard S. Traisman +2 more
openalex +2 more sources
Neonatal seizures: Advances in diagnosis and management
Epilepsia Open, EarlyView.Abstract The International League Against Epilepsy (ILAE) created the ILAE Neonatal Task Force that classified neonatal seizures, defined neonatal epilepsy syndromes, and specified treatment guidelines. These frameworks, in addition to improved access to genetic testing and other recent advances, have revolutionized the diagnosis and management of ...
Elissa G. Yozawitz +2 more
wiley +1 more source
The Effect of Adrenergic Blockade on the Glucagon Responses to Starvation and Hypoglycemia in Man [PDF]
, 1974 Robert M. Walter +3 more
openalex +1 more source
Journal of the American Medical Association (JAMA), 2017 C. Wysham +7 more
semanticscholar +1 more source
Epilepsia Open, EarlyView.Abstract Objective Due to the conflicting evidence and expected regional therapeutic variations for cost‐effectiveness in children with infantile epileptic spasms syndrome (IESS), this study assessed treatment effectiveness, safety, Health‐Related Quality of Life (HRQoL), and performed a cost‐effectiveness analysis (CEA) for hormonal therapies in ...
Nagita Devi +4 more
wiley +1 more source